The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 ...
Presentations Included First Human Data on EVAâ„¢, Saluda's Automated SCS Programming Platform MINNEAPOLIS, Feb. 5, 2025 ...
Christian Fellowship Center Lead Pastor Brian Dube is making a miraculous recovery from a case of near-fatal paralysis from a ...
GBS is a rare disorder where the immune system attacks the peripheral nervous system which carries signals from the brain and spinal cord to the rest of the body, causing muscle weakness and paralysis ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...
ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Seven women filed for re-sentencing under the Oklahoma Survivors Act, a new law that considers domestic violence evidence.
Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results